A California court has ordered PC Spes manufacturer Dr. Sophie Chen and International Medical Research, Incorporated (doing business as BotanicLab) to pay more than $24 million to consumers who bought PC Spes between 1998 and 2002. PC Spes, a purported herbal supplement targeted at prostate cancer patients, is no longer sold in the USA but reportedly is sold in Europe and the UK from the Netherlands.

The judgment was based on evidence of intent to defraud consumers and to loot company assets to avoid restitution.

“Contrary to the IMR Defendants representations, PC Spes was not all natural, was not all herbal, was not a dietary supplement, and was in fact a very dangerous product,” said Superior Court judge John S. Meyer, who presided over the case August 6-7 in San Diego.

In an exclusive report August 10, psa-rising.com published details of the judgment and a link to the full transcript (in .pdf).